Phibro Animal Health Corporation (PAHC)
NASDAQ: PAHC · Real-Time Price · USD
39.62
-1.57 (-3.81%)
At close: Sep 12, 2025, 4:00 PM EDT
39.70
+0.08 (0.20%)
After-hours: Sep 12, 2025, 6:36 PM EDT
Phibro Animal Health Stock Forecast
Stock Price Forecast
The 4 analysts that cover Phibro Animal Health stock have a consensus rating of "Hold" and an average price target of $27.5, which forecasts a -30.59% decrease in the stock price over the next year. The lowest target is $22 and the highest is $35.
Price Target: $27.5 (-30.59%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Phibro Animal Health stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Buy | 0 | 0 | 0 | 1 | 1 | 1 |
Hold | 2 | 2 | 2 | 1 | 1 | 1 |
Sell | 2 | 2 | 2 | 2 | 2 | 2 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
B of A Securities | B of A Securities | Sell Maintains $19 → $27 | Sell | Maintains | $19 → $27 | -31.85% | Aug 29, 2025 |
JP Morgan | JP Morgan | Hold → Buy Upgrades $25 → $35 | Hold → Buy | Upgrades | $25 → $35 | -11.66% | Jul 7, 2025 |
Morgan Stanley | Morgan Stanley | Hold Maintains $21 → $26 | Hold | Maintains | $21 → $26 | -34.38% | Jun 25, 2025 |
Morgan Stanley | Morgan Stanley | Hold Maintains $20 → $21 | Hold | Maintains | $20 → $21 | -47.00% | May 8, 2025 |
Barclays | Barclays | Sell Maintains $20 → $22 | Sell | Maintains | $20 → $22 | -44.47% | Feb 10, 2025 |
Financial Forecast
Revenue This Year
1.47B
from 1.30B
Increased by 13.56%
Revenue Next Year
1.52B
from 1.47B
Increased by 3.06%
EPS This Year
2.37
from 1.19
Increased by 98.86%
EPS Next Year
2.69
from 2.37
Increased by 13.65%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2026 | 2027 | 2028 |
---|---|---|---|
High | 1.5B | 1.6B | |
Avg | 1.5B | 1.5B | |
Low | 1.4B | 1.4B |
Revenue Growth
Revenue Growth | 2026 | 2027 | 2028 |
---|---|---|---|
High | 18.9% | 7.5% | |
Avg | 13.6% | 3.1% | |
Low | 8.5% | -1.9% |
EPS Forecast
EPS | 2026 | 2027 | 2028 |
---|---|---|---|
High | 2.55 | 2.82 | |
Avg | 2.37 | 2.69 | |
Low | 2.16 | 2.52 |
EPS Growth
EPS Growth | 2026 | 2027 | 2028 |
---|---|---|---|
High | 114.4% | 19.4% | |
Avg | 98.9% | 13.6% | |
Low | 81.2% | 6.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.